Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Interventional × IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 368 Carcinoma, Non-Small-Cell Lung 310 Neoplasms 290 Prostatic Neoplasms 242 Colorectal Neoplasms 191 Lung Neoplasms 183 Neoplasm Metastasis 169 Leukemia, Myeloid, Acute 168 Multiple Myeloma 152 Ovarian Neoplasms 142 Melanoma 119 Pancreatic Neoplasms 105 Recurrence 99 Squamous Cell Carcinoma of Head and Neck 95 Brain Neoplasms 89 Glioblastoma 87 Triple Negative Breast Neoplasms 85 Lymphoma 84 Uterine Cervical Neoplasms 81 Endometrial Neoplasms 79 Carcinoma, Renal Cell 79 Precursor Cell Lymphoblastic Leukemia-Lymphoma 78 Glioma 77 Carcinoma, Hepatocellular 76 Stomach Neoplasms 73 Urinary Bladder Neoplasms 72 Myelodysplastic Syndromes 69 Lymphoma, Non-Hodgkin 69 Lymphoma, Large B-Cell, Diffuse 66 Sarcoma 65

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡